Table I.
Entrez gene ID | Fold change (log2 ratio) | Gene name | Target sites | |||
---|---|---|---|---|---|---|
Symbol | BOY | T24 | Average | |||
59274 | MESDC1 | −2.01 | −1.59 | −1.80 | Mesoderm development candidate 1 | + |
10950 | BTG3 | −1.88 | −1.34 | −1.61 | BTG family, member 3 | + |
27430 | MAT2B | −1.47 | −1.41 | −1.44 | Methionine adenosyltransferase II, beta | + |
11160 | ERLIN2 | −1.61 | −1.15 | −1.38 | ER lipid raft associated 2 | − |
2021 | ENDOG | −1.41 | −1.28 | −1.34 | Endonuclease G | + |
340508 | LOC340508 | −1.54 | −1.09 | −1.31 | Hypothetical protein LOC340508 | − |
117178 | SSX2IP | −1.37 | −1.05 | −1.21 | Synovial sarcoma, X breakpoint 2 interacting protein | + |
285761 | DCBLD1 | −1.40 | −1.00 | −1.20 | Discoidin, CUB and LCCL domain containing 1 | + |
122416 | ANKRD9 | −1.19 | −1.16 | −1.17 | Ankyrin repeat domain 9 | + |
3363 | HTR7 | −1.16 | −1.03 | −1.09 | 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) | + |
246329 | STAC3 | −1.01 | −1.05 | −1.03 | SH3 and cysteine rich domain 3 | − |